Johns Hopkins ABX Guide
Diloxanide furoate
Diloxanide furoate is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Drug not currently available for use in the U.S.
- Also known in the literature as entamide furoate or entamide.
- CDC conducted a study on the investigational use of the drug between 1977-1990.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Amebiasis, limited to the GI lumen, caused by Entamoeba histolytica.
- As a combination therapy with other antiprotozoals, such as nitroimidazoles, for treating invasive or extraintestinal amebiasis. Diloxanide furoate is not a tissue amoebicide. Therefore, in extraintestinal infections of E. histolytica, another agent (specifically a "tissue amoebicide" like metronidazole) should be considered for use with diloxanide furoate.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Drug not currently available for use in the U.S.
- Also known in the literature as entamide furoate or entamide.
- CDC conducted a study on the investigational use of the drug between 1977-1990.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Amebiasis, limited to the GI lumen, caused by Entamoeba histolytica.
- As a combination therapy with other antiprotozoals, such as nitroimidazoles, for treating invasive or extraintestinal amebiasis. Diloxanide furoate is not a tissue amoebicide. Therefore, in extraintestinal infections of E. histolytica, another agent (specifically a "tissue amoebicide" like metronidazole) should be considered for use with diloxanide furoate.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 18, 2022
Citation
Auwaerter, Paul G, and Kathryn Dzintars. "Diloxanide Furoate." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540198/all/Diloxanide_furoate.
Auwaerter PG, Dzintars K. Diloxanide furoate. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540198/all/Diloxanide_furoate. Accessed March 24, 2023.
Auwaerter, P. G., & Dzintars, K. (2022). Diloxanide furoate. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540198/all/Diloxanide_furoate
Auwaerter PG, Dzintars K. Diloxanide Furoate [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 March 24]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540198/all/Diloxanide_furoate.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Diloxanide furoate
ID - 540198
A1 - Auwaerter,Paul,M.D.
AU - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2022/10/18/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540198/all/Diloxanide_furoate
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
